Seller record · Telehealth service

New Wave Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program pages, the footer and the terms refer only to partner compounding pharmacies and state-licensed compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

New Wave HealthTelehealth service

6/8criteria passed

Price: Semaglutide from $139 a month, tirzepatide from $149
Sells: semaglutide injection, tirzepatide injection, GLP-1 microdose, and 5 more
FDA letters: None on file

Visit New Wave Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Virginia Beach telehealth platform selling compounded semaglutide and tirzepatide injections, a GLP-1 microdose program and an oral GLP-1 alongside a whole-health plan, with tesamorelin, sermorelin, NAD+ and PT-141 on its peptides page. Monthly starting prices are printed, and no dispensing pharmacy is named.

Operating entity New Wave Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	New Wave Health's about page; New Wave Health's semaglutide product page; New Wave Health's website
S2	Prescription gating	PASS	New Wave Health's website; New Wave Health's semaglutide product page; New Wave Health's terms
S3	Pharmacy identification	FAIL	New Wave Health's semaglutide product page; New Wave Health's terms
S4	Compounding disclosure	PASS	New Wave Health's website; New Wave Health's peptides page
S5	Analytical documentation	FAIL	New Wave Health's peptides page; New Wave Health's terms
S6	Business address	PASS	New Wave Health's contact page; New Wave Health's terms; New Wave Health's privacy page
S7	Price disclosure	PASS	New Wave Health's peptides page; New Wave Health's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSLicensed providers review each health profile and direct every dose, the program answers say each consultation is reviewed and authorized by a licensed provider, and the footer says every prescription decision is made by an independent licensed practitioner.Source: New Wave Health's about page; New Wave Health's semaglutide product page; New Wave Health's website.

S2PASSThe home page lists an online intake of health history, goals and baseline as the first step and says a provider reviews every plan before anything moves forward, and the program pages say pricing is reviewed with the buyer before anything is charged. The terms refund an order when the provider declines to prescribe.Source: New Wave Health's website; New Wave Health's semaglutide product page; New Wave Health's terms.

S3FAILNo filling pharmacy is named. The program pages, the footer and the terms refer only to partner compounding pharmacies and state-licensed compounding pharmacies.Source: New Wave Health's semaglutide product page; New Wave Health's terms.

S4PASSThe disclaimer at the foot of every page and the note beneath the peptides price list state that compounded medications are not FDA-approved, and the home page adds that compounded semaglutide and tirzepatide are not the same as the branded medications.Source: New Wave Health's website; New Wave Health's peptides page.

S5FAILNo certificate of analysis or lot document is published on the program pages, the peptide pages, the terms, the privacy policy or the HIPAA notice.Source: New Wave Health's peptides page; New Wave Health's terms.

S6PASSNew Wave Health LLC at 1832 Kempsville Road, Suite 112, Virginia Beach, VA 23464, printed on the contact page, in the footer of every page, as the notice address in the terms and as the mailing address in the privacy policy. The terms name Delaware law.Source: New Wave Health's contact page; New Wave Health's terms; New Wave Health's privacy page.

S7PASSThe semaglutide injection from $139 a month, the tirzepatide injection from $149, the GLP-1 microdose from $199 and the oral GLP-1 from $229 a month. Tesamorelin from $299, sermorelin and PT-141 from $249 and NAD+ from $199 a month. The home page prints plans from $139 a month, and the program pages print no figure.Source: New Wave Health's peptides page; New Wave Health's website.

S8PASSNo FDA warning letter names New Wave Health or New Wave Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, GLP-1 microdose, GLP-1 oral, tesamorelin, sermorelin, NAD+, PT-141.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells PT-141 Who sells tesamorelin

Visit New Wave Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.